Microbiopsy-based minimally invasive skin sampling for molecular analysis is acceptable to Epidermolysis Bullosa Simplex patients where conventional diagnostic biopsy was refused

dc.contributor.authorYamada, M.
dc.contributor.authorMelville, E.
dc.contributor.authorCowin, A.J.
dc.contributor.authorProw, T.W.
dc.contributor.authorKopecki, Z.
dc.date.issued2021
dc.descriptionLetter to the Editor
dc.description.abstractAbstract not available.
dc.description.statementofresponsibilityMiko Yamada, Elizabeth Melville, Allison J. Cowin, Tarl W. Prow, Zlatko Kopecki
dc.identifier.citationSkin Research and Technology, 2021; 27(3):461-463
dc.identifier.doi10.1111/srt.12971
dc.identifier.issn0909-752X
dc.identifier.issn1600-0846
dc.identifier.orcidCowin, A.J. [0000-0003-2885-2080]
dc.identifier.orcidKopecki, Z. [0000-0002-8072-4222]
dc.identifier.urihttp://hdl.handle.net/2440/129314
dc.language.isoen
dc.publisherWiley
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/GNT1102617
dc.rights© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
dc.source.urihttps://doi.org/10.1111/srt.12971
dc.subjectSkin
dc.subjectHumans
dc.subjectEpidermolysis Bullosa Simplex
dc.subjectBiopsy
dc.subjectSpecimen Handling
dc.titleMicrobiopsy-based minimally invasive skin sampling for molecular analysis is acceptable to Epidermolysis Bullosa Simplex patients where conventional diagnostic biopsy was refused
dc.typeJournal article
pubs.publication-statusPublished

Files